Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Cannae Holdings
CNNE
$1.11B
| $3.06M | ﹤0.01% |
151,494
-22,700
| -13% | -$458K |
|
1577
Par Pacific Holdings
PARR
$1.67B
| $3.04M | ﹤0.01% |
104,159
-12,000
| -10% | -$350K |
|
1578
3D Systems Corporation
DDD
$286M
| $3.03M | ﹤0.01% |
283,050
-31,500
| -10% | -$338K |
|
1579
The Bancorp
TBBK
$3.5B
| $3.03M | ﹤0.01% |
108,700
-14,300
| -12% | -$398K |
|
1580
Enova International
ENVA
$2.88B
| $3.02M | ﹤0.01% |
67,900
-9,300
| -12% | -$413K |
|
1581
Palomar
PLMR
$3.13B
| $3.01M | ﹤0.01% |
54,500
-6,400
| -11% | -$353K |
|
1582
Hillman Solutions
HLMN
$1.92B
| $3M | ﹤0.01% |
356,800
+122,100
| +52% | +$1.03M |
|
1583
Virtus Investment Partners
VRTS
$1.34B
| $2.99M | ﹤0.01% |
15,700
-1,900
| -11% | -$362K |
|
|
EVBG
1584
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.99M | ﹤0.01% |
86,200
-9,700
| -10% | -$336K |
|
1585
Avanos Medical
AVNS
$567M
| $2.99M | ﹤0.01% |
100,400
-11,800
| -11% | -$351K |
|
1586
Middlesex Water
MSEX
$971M
| $2.98M | ﹤0.01% |
38,162
-4,300
| -10% | -$336K |
|
1587
Ero Copper
ERO
$1.75B
| $2.98M | ﹤0.01% |
168,700
-18,500
| -10% | -$327K |
|
1588
Luminar Technologies
LAZR
$129M
| $2.98M | ﹤0.01% |
30,580
-3,007
| -9% | -$293K |
|
1589
Gates Industrial
GTES
$6.6B
| $2.96M | ﹤0.01% |
213,400
-25,200
| -11% | -$350K |
|
1590
nCino
NCNO
$3.48B
| $2.96M | ﹤0.01% |
119,600
-13,500
| -10% | -$335K |
|
|
NVEE
1591
DELISTED
NV5 Global
NVEE
| $2.96M | ﹤0.01% |
114,000
-13,600
| -11% | -$353K |
|
|
ALEX
1592
Alexander & Baldwin
ALEX
$1.34B
| $2.96M | ﹤0.01% |
156,620
-19,000
| -11% | -$359K |
|
1593
Provident Financial Services
PFS
$2.59B
| $2.96M | ﹤0.01% |
154,400
-18,300
| -11% | -$351K |
|
1594
Abercrombie & Fitch
ANF
$4.12B
| $2.96M | ﹤0.01% |
106,700
-12,800
| -11% | -$355K |
|
1595
Griffon
GFF
$3.61B
| $2.96M | ﹤0.01% |
92,400
-10,900
| -11% | -$349K |
|
1596
Horace Mann Educators
HMN
$1.94B
| $2.96M | ﹤0.01% |
88,300
-10,400
| -11% | -$348K |
|
1597
Weis Markets
WMK
$1.75B
| $2.95M | ﹤0.01% |
34,900
-4,100
| -11% | -$347K |
|
1598
Archrock
AROC
$4.29B
| $2.95M | ﹤0.01% |
302,200
-36,000
| -11% | -$352K |
|
1599
Marten Transport
MRTN
$953M
| $2.93M | ﹤0.01% |
139,975
-16,600
| -11% | -$348K |
|
1600
Celldex Therapeutics
CLDX
$1.62B
| $2.93M | ﹤0.01% |
81,400
-8,900
| -10% | -$320K |
|